FOXP1 and non-small cell lung carcinoma: Differential methylation has also been associated with increased risk of recurrence in NSCLC and breast cancers (93, 94), and methylation of a CpG in the transcription factor FOXP1 is predictive of response to ICB in NSCLC patients (95).